Subcutaneous Isatuximab by On-Body-Injector plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: ISASOCUT study
Arthur Bobin, Cyrille Touzeau, Nicolas Branche, A. Perrot et autres
0 citationsResearch Square